The antibiotic course has had its day

BMJ (Online)

Volumn 358, Issue , 2017, Pages

  Llewelyn, Martin J ^a,b   Fitzpatrick, Jennifer M ^b   Darwin, Elizabeth ^c   Sarahtonkin Crine, ^d   Gorton, Cliff ^e   Paul, John ^f   Peto, Tim E A ^g   Yardley, Lucy ^h   Hopkins, Susan ⁱ   Walker, Ann Sarah ^c  

^a BRIGHTON AND SUSSEX MEDICAL SCHOOL   (United Kingdom)

^b UK   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e Oriel College Oxford   (United Kingdom)

^f ROYAL SUSSEX COUNTY HOSPITAL   (United Kingdom)

^g NIHR OXFORD BIOMEDICAL RESEARCH CENTRE   (United Kingdom)

^h UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

ⁱ ROYAL FREE LONDON NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAM; CIPROFLOXACIN; LEVOFLOXACIN; MACROLIDE; PENICILLIN DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ANTIMICROBIAL ACTIVITY; DRUG EFFICACY; DRUG SAFETY; HUMAN; NONHUMAN; PATIENT CARE; PRIORITY JOURNAL; RISK ASSESSMENT; SHORT SURVEY; TREATMENT DURATION; TREATMENT OUTCOME; ANTIMICROBIAL STEWARDSHIP; CLINICAL PRACTICE; DRUG ADMINISTRATION; RISK; STANDARDS;

ANTI-BACTERIAL AGENTS; ANTIMICROBIAL STEWARDSHIP; DRUG ADMINISTRATION SCHEDULE; DRUG RESISTANCE, MICROBIAL; HUMANS; PRACTICE PATTERNS, PHYSICIANS'; RISK;

EID: 85026518920     PISSN: 09598146     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.j3418     Document Type: Short Survey

References (40)

1. Goossens H, Ferech M, Vander Stichele R, Elseviers M. ESAC Project Group. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 2005;358:579-87. doi:10. 1016/S0140-6736(05)70799-6 pmid:15708101.
2. Costelloe C, Metcalfe C, Lovering A, Mant D, Hay AD. Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis. BMJ 2010;358:c2096. doi:10. 1136/bmj. c2096. pmid:20483949.
3. World Health Organization. Global action plan on antimicrobial resistance 2015. http:// www. wpro. who. int/entity/drug-resistance/resources/global-action-plan-eng. pdf
4. World Health Organization. How to stop antibiotic resistance? Here's a WHO prescription. 2015. http://www. who. int/mediacentre/commentaries/stop-antibiotic-resistance/en/
5. NPS Medicinewise. Antibiotic resistance: the facts. https://www. nps. org. au/medical-info/ consumer-info/antibiotic-resistance-the-facts
6. National Collaborating Centre for Infectious Diseases. Antibiotic use and resistance: information for patients. https://nccid. ca/antibiotic-awareness/
7. Federal Drugs Administration. Combatting antibiotic resistance. Follow directions for proper use. https://www. fda. gov/ForConsumers/ConsumerUpdates/ucm092810. htm# follow
8. European Antibiotic Awareness Day. Factsheet for general public. http://ecdc. europa. eu/ en/eaad/antibiotics-get-informed/Pages/get-informed. aspx
9. Assessment and Qualifications Alliance. GCSE biology specification. http://www. aqa. org. uk/subjects/science/gcse/biology-8461
10. Centers for Disease Control. Get smart about antibiotics. What you can do. https://www. cdc. gov/getsmart/community/about/can-do. html
11. UK Government. Antibiotic awareness resources 2016. https://www. gov. uk/government/ collections/european-antibiotic-awareness-day-resources
12. Abraham EP, Chain E, Fletcher CM, et al. Further observations on penicillin. Lancet 1941;358:177-89doi:10. 1016/S0140-6736(00)72122-2.
13. Fleming A. On the antibacterial action of cultures of a penicillium, with special reference to their use in the isolation of B. influenzae. Br J Exp Pathol 1929;358:226-36.
14. Fleming A. Penicillin. Nobel lecture, 11 Dec 1945. https://www. nobelprize. org/nobel-prizes/ medicine/laureates/1945/fleming-lecture. pdf
15. Medical Research Countil. Streptomycin treatment of pulmonary tuberculosis. Br Med J 1948;358:769-82. doi:10. 1136/bmj. 2. 4582. 769 pmid:18890300.
16. Crémieux A-C, Muller-Serieys C, Panhard X, et al. Emergence of resistance in normal human aerobic commensal flora during telithromycin and amoxicillin-clavulanic acid treatments. Antimicrob Agents Chemother 2003;358:2030-5. doi:10. 1128/AAC. 47. 6. 2030-2035. 2003 pmid:12760893.
17. Lodise TP, Miller CD, Graves J, et al. Clinical prediction tool to identify patients with Pseudomonas aeruginosa respiratory tract infections at greatest risk for multidrug resistance. Antimicrob Agents Chemother 2007;358:417-22. doi:10. 1128/AAC. 00851-06 pmid:17158943.
18. Sheppard AE, Stoesser N, Wilson DJ, et al. Modernising Medical Microbiology (MMM) Informatics Group. Nested Russian doll-like genetic mobility drives rapid dissemination of the carbapenem resistance gene blaKPC. Antimicrob Agents Chemother 2016;358:3767-78. doi:10. 1128/AAC. 00464-16 pmid:27067320.
19. Hoberman A, Paradise JL, Rockette HE, et al. Shortened Antimicrobial Treatment for Acute Otitis Media in Young Children. N Engl J Med 2016;358:2446-56. doi:10. 1056/ NEJMoa1606043 pmid:28002709.
20. Altamimi S, Khalil A, Khalaiwi KA, Milner RA, Pusic MV, Al Othman MA. Short-term late-generation antibiotics versus longer term penicillin for acute streptococcal pharyngitis in children. Cochrane Database Syst Rev 2012;8:CD004872. pmid:22895944.
21. Uranga A, España PP, Bilbao A, et al. Duration of antibiotic treatment in community-acquired pneumonia: a multicenter randomized clinical trial. JAMA Intern Med 2016;358:1257-65. doi:10. 1001/jamainternmed. 2016. 3633. pmid:27455166.
22. Hepburn MJ, Dooley DP, Skidmore PJ, Ellis MW, Starnes WF, Hasewinkle WC. Comparison of short-course (5 days) and standard (10 days) treatment for uncomplicated cellulitis. Arch Intern Med 2004;358:1669-74. doi:10. 1001/archinte. 164. 15. 1669 pmid: 15302637.
23. Sandberg T, Skoog G, Hermansson AB, et al. Ciprofloxacin for 7 days versus 14 days in women with acute pyelonephritis: a randomised, open-label and double-blind, placebo-controlled, non-inferiority trial. Lancet 2012;358:484-90. doi:10. 1016/S0140-6736( 12)60608-4 pmid:22726802.
24. Peterson J, Kaul S, Khashab M, Fisher AC, Kahn JB. A double-blind, randomized comparison of levofloxacin 750 mg once-daily for five days with ciprofloxacin 400/500 mg twice-daily for 10 days for the treatment of complicated urinary tract infections and acute pyelonephritis. Urology 2008;358:17-22. doi:10. 1016/j. urology. 2007. 09. 002 pmid:18242357.
25. Chastre J, Wolff M, Fagon JY, et al. PneumA Trial Group. Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial. JAMA 2003;358:2588-98. doi:10. 1001/jama. 290. 19. 2588 pmid:14625336.
26. Singh N, Rogers P, Atwood CW, Wagener MM, Yu VL. Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription. Am J Respir Crit Care Med 2000;358:505-11. doi:10. 1164/ajrccm. 162. 2. 9909095 pmid:10934078.
27. Sawyer RG, Claridge JA, Nathens AB, et al. Trial of short-course antimicrobial therapy for intraabdominal infection. N Engl J Med 2015;358:1996-2005. doi:10. 1056/ NEJMoa1411162 pmid:25992746.
28. Spellberg B. The new antibiotic mantra-"shorter is better". JAMA Intern Med 2016;358:1254-5. doi:10. 1001/jamainternmed. 2016. 3646 pmid:27455385.
29. Gupta K, Hooton TM, Naber KG, et al. Infectious Diseases Society of America European Society for Microbiology and Infectious Diseases. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis 2011;358:e103-20. doi:10. 1093/cid/ ciq257 pmid:21292654.
30. Schuetz P, Chiappa V, Briel M, Greenwald JL. Procalcitonin algorithms for antibiotic therapy decisions: a systematic review of randomized controlled trials and recommendations for clinical algorithms. Arch Intern Med 2011;358:1322-31. doi:10. 1001/ archinternmed. 2011. 318 pmid:21824946.
31. Brookes-Howell L, Elwyn G, Hood K, et al. 'The body gets used to them': patients' interpretations of antibiotic resistance and the implications for containment strategies. J Gen Intern Med 2012;358:766-72. doi:10. 1007/s11606-011-1916-1 pmid:22065334.
32. McCullough AR, Parekh S, Rathbone J, Del Mar CB, Hoffmann TC. A systematic review of the public's knowledge and beliefs about antibiotic resistance. J Antimicrob Chemother 2016;358:27-33. doi:10. 1093/jac/dkv310 pmid:26459555.
33. Little P, Moore M, Kelly J, et al. PIPS Investigators. Delayed antibiotic prescribing strategies for respiratory tract infections in primary care: pragmatic, factorial, randomised controlled trial. BMJ 2014;358:g1606. doi:10. 1136/bmj. g1606 pmid:24603565.
34. Little P, Stuart B, Francis N, et al. GRACE consortium. Effects of internet-based training on antibiotic prescribing rates for acute respiratory-tract infections: a multinational, cluster, randomised, factorial, controlled trial. Lancet 2013;358:1175-82. doi:10. 1016/S0140-6736( 13)60994-0 pmid:23915885.
35. Butler CC, Simpson SA, Dunstan F, et al. Effectiveness of multifaceted educational programme to reduce antibiotic dispensing in primary care: practice based randomised controlled trial. BMJ 2012;358:d8173. doi:10. 1136/bmj. d8173 pmid:22302780.
36. Llewelyn MJ, Hand K, Hopkins S, Walker AS. Antibiotic policies in acute English NHS trusts: implementation of "start smart-then focus" and relationship with Clostridium difficile infection rates. J Antimicrob Chemother 2015;358:1230-5. pmid:25538165.
37. Davey P, Brown E, Charani E, et al. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev 2013;358:CD003543. pmid:23633313.
38. Lambert HP. Don't keep taking the tablets?Lancet 1999;358:943-5. doi:10. 1016/S0140-6736(99)01139-3 pmid:10489971.
39. UK Government. Start smart then focus. Antimicrobial stewardship toolkit for English hospitals. https://www. gov. uk/government/publications/antimicrobial-stewardship-startsmart-then-focus
40. Horne R, Chapman SC, Parham R, Freemantle N, Forbes A, Cooper V. Understanding patients' adherence-related beliefs about medicines prescribed for long-term conditions: a meta-analytic review of the necessity-concerns framework. PLoS One 2013;358:e80633. doi:10. 1371/journal. pone. 0080633 pmid:24312488.